Finance

Lists
Why is 300255 down 2,02%?
Dive Deeper
300255:SHE
Hebei Changshan Biochemical Pharm Co Ltd
19,88 CN¥
-2,02%
(-0,41) 1D
16 қаз., 15:04:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300255...
Open
20,65 CN¥
High
21,15 CN¥
Low
19,75 CN¥
Mkt. cap
18,65 млрд
Avg. vol.
17,59 млн
Volume
21,03 млн
52-wk high
71,71 CN¥
52-wk low
19,75 CN¥
EPS
-0,38 CN¥
Shares outstanding
919,06 млн
No. of employees
1 мың
Open
20,65 CN¥
High
21,15 CN¥
Low
19,75 CN¥
Mkt. cap
18,65 млрд
Avg. vol.
17,59 млн
Volume
21,03 млн
52-wk high
71,71 CN¥
52-wk low
19,75 CN¥
EPS
-0,38 CN¥
Shares outstanding
919,06 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Hebei Changshan Biochemical Pharm Co Ltd
CEO-
Employees1,19 мың
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
189,61 млн
193,91 млн
256,10 млн
219,72 млн
Cost of goods sold
164,51 млн
281,46 млн
193,11 млн
179,86 млн
Cost of revenue
164,51 млн
281,46 млн
193,11 млн
179,86 млн
Research and development expenses
8,72 млн
9,51 млн
7,23 млн
8,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
29,72 млн
91,72 млн
30,76 млн
30,39 млн
Operating expense
33,60 млн
143,40 млн
38,30 млн
42,40 млн
Total operating expenses
198,11 млн
424,86 млн
231,40 млн
222,26 млн
Operating income
-8,50 млн
-230,95 млн
24,70 млн
-2,54 млн
Other non operating income
-1,50 млн
-28,67 млн
-3,36 млн
3,51 млн
EBT including unusual items
-21,20 млн
-301,55 млн
5,20 млн
-24,37 млн
EBT excluding unusual items
-34,61 млн
-282,26 млн
-355,86 м.
-25,59 млн
Income tax expense
-435,25 м.
8,93 млн
1,82 млн
761,85 м.
Effective tax rate
2,05%
-2,96%
35,03%
-3,13%
Other operating expenses
-723,45 м.
5,43 млн
2,02 млн
759,88 м.
Net income
-15,73 млн
-313,08 млн
5,87 млн
-22,63 млн
Net profit margin
-8,29%
-161,45%
2,29%
-10,30%
Earnings per share
-
-
-
-
Interest and investment income
2,00 млн
531,86 м.
117,28 м.
28,28 мың
Interest expense
-19,57 млн
-28,42 млн
-21,82 млн
-23,56 млн
Net interest expenses
-17,56 млн
-27,89 млн
-21,70 млн
-23,53 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
9,49 млн
-214,14 млн
41,52 млн
14,11 млн
Gain or loss from assets sale
17,64 мың
228,40 м.
-
6,30 мың
AI content may include mistakes. Learn more
Google қолданбалары